Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,375 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06360900Recruiting
Vagus nerve stimulation study for functional dyspepsia
This trial tests a combination of a non-invasive nerve stimulation device and supportive therapy to help people with functional dyspepsia. The goal is to improve digestion and reduce stomach pain.
Boston, MassachusettsAges 18–65 - NCT06327997RecruitingEarly Phase 1
Fast CAR-T cells for advanced solid tumors
This trial tests a new type of 'fast CAR-T' cell therapy for people with advanced solid tumors that have not been helped by standard treatments. CAR-T cells are a kind of immune cell that is reprogrammed to attack cancer cells that carry certain markers called mesothelin, MUC1, and PD-L1.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06306833Recruiting
Biofeedback therapy for chronic low back pain
This study tests if a therapy that uses special sensors to help you relax your back muscles (called surface EMG biofeedback) can reduce chronic low back pain. If you have ongoing low back pain for at least 3 months, you may be able to join.
Karachi, SindhAges 25–75 - NCT06325774Recruiting
Shorter radiation for localized prostate cancer
This trial tests a shorter, more intense course of radiation (hypofractionated radiotherapy) for men with localized prostate cancer that hasn't spread. It aims to see if this treatment is safe and effective and may reduce the number of hospital visits.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06174285Recruiting
Psychedelic VR therapy for depression
This trial tests a new approach that combines virtual reality (VR) with a psychedelic-like experience to help people with depression. The therapy is designed to be used safely in a clinic and aims to improve mood and well-being.
Tallinn, HarjuAges 18–65 - NCT06320067RecruitingPhase 3
Testing treatments for metastatic hormone-sensitive prostate cancer
This trial tests two newer treatments—targeted radiation (SABR) or a special radioactive drug (Lu-177 PSMA-617)—added to standard hormone therapy for men with prostate cancer that has spread. The goal is to see if these additional treatments help control the cancer better.
BarnsleyAges 18 years+ - NCT06320262Recruiting
Wet cupping (Hijama) for fibromyalgia pain
This trial tests whether wet cupping (Hijama) can help reduce pain in women with fibromyalgia. It is for women who have had moderate to severe pain and have not taken certain pain medications in the past year.
CairoAges 18–55 - NCT06304077Recruiting
VR walking therapy for older adults in rehab
This trial tests whether virtual reality can make walking therapy more engaging and effective for older adults in a hospital rehab program. It is for German-speaking inpatients over 65 who can walk at least 30 meters with or without a walking aid.
Schaffhausen, Canton of SchaffhausenAges 65 years+ - NCT06311942RecruitingPhase 4
Comparing triple vs. dual therapy after liver surgery for liver cancer
This trial tests whether adding a third drug to standard two-drug therapy after liver surgery helps prevent liver cancer from returning. It is for people who have a specific blood vessel pattern in their tumor, called VETC, seen on a special stain.
Wuhan, HubeiAges 18–75 - NCT06281405RecruitingPhase 2
CAPOX and immunotherapy with or without radiation for rectal cancer
This trial tests whether adding radiation therapy to a combination of chemotherapy (CAPOX) and an immunotherapy drug (PD-1 antibody) is more effective than the combination alone for people with locally advanced rectal cancer that is MSS (microsatellite stable) or pMMR. It aims to improve outcomes for patients with high-risk features.
ShanghaiAges 18–70 - NCT06321536RecruitingPhase 2
Testing microbiota therapy for resistant bacteria in the gut
This study tests a treatment made from healthy donor stool (called microbiota therapy) given as an enema or through a feeding tube. It aims to help people who carry resistant bacteria that are hard to treat, by reducing or clearing those bacteria from the gut.
Atlanta, GeorgiaAges 18 years+ - NCT06223607Recruiting
Dual antiplatelet therapy in patients with low platelets
This trial looks at whether taking two blood thinners (aspirin plus clopidogrel or ticagrelor) after a heart stent procedure is safe and effective for people who already have low platelet counts. It may help doctors decide the best treatment for you if you have both low platelets and a stent.
Dallas, TexasAges 18 years+ - NCT06226844Recruiting
Can a vibration device help people with leg artery disease walk further?
This study tests a device called BeatMove to see if it can improve walking distance for people with blocked leg arteries that cause pain when walking. It may help if you have this condition and already take medicines for it.
NîmesAges 18 years+ - NCT06165536Recruiting
Using voice strategies to reduce vocal fold pressure
This study tests different ways of using your voice to reduce pressure on vocal fold lesions caused by overuse. If you are between 18 and 40, have been diagnosed with such lesions, and are going to voice therapy, you may be able to join.
Los Angeles, CaliforniaAges 18–40 - NCT06256705Recruiting
Study of targeted radiation for neuroendocrine tumors
This study follows people with a type of digestive tract cancer called GEP-NET that has spread and is growing. It uses a special imaging scan to find tumors that absorb a radioactive drug, then treats them with targeted radiation therapy. The goal is to learn more about who benefits most from this treatment.
ClichyAges 18 years+ - NCT06263712Recruiting
Can brief therapy after a suicide attempt help?
This study tests whether a short therapy program (ASSIP) can help reduce suicide risk by looking at how people think and feel after a suicide attempt. It may be a good fit if you've had a past attempt and are open to a brief, focused therapy.
BernAges 18 years+ - NCT06215651RecruitingPhase 2
Testing cadonilimab and lenvatinib before liver cancer surgery
This study tests whether a combination of two drugs (cadonilimab and lenvatinib) can shrink liver cancer enough to make it removable by surgery for people whose cancer was previously too advanced for surgery. You may qualify if your cancer hasn't spread far, you haven't had treatment before, and your liver is still working fairly well.
Beijing, Beijing MunicipalityAges 18–75 - NCT06195228RecruitingPhase 4
Real-world study of genetic types in advanced thyroid cancer
This study looks at how different genetic types of advanced thyroid cancer respond to treatment in real-world settings. It may help doctors choose the best therapy for you based on your tumor’s genetic makeup.
Fuzhou, FujianAges Any age - NCT06311929RecruitingPhase 4
Personalized treatment after liver cancer surgery
This trial tests a tailored treatment plan after surgery for liver cancer that shows a specific blood vessel pattern (VETC). The goal is to find the best follow-up therapy to lower the chance of cancer coming back.
Wuhan, HubeiAges 18–75 - NCT06078709RecruitingPhase 2
Pre-surgery radiation and chemo for esophageal cancer
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
Scottsdale, ArizonaAges 18 years+ - NCT06247501RecruitingPhase 2
CAR-T therapy for children with B-cell ALL needing transplant
This study tests a new type of immune-cell therapy (called CAR-T cells) for children and young adults with a specific blood cancer (B-cell ALL) who need a stem cell transplant. The treatment uses a patient's own T-cells that are modified to find and kill cancer cells with the CD19 marker.
SeoulAges Up to 25 years - NCT06022419Recruiting
Comparing two treatments for finger fractures
This trial compares two non-surgical treatments for fractures of the finger bone closest to the hand. It will help find out which approach—a special cast or a simple splint—works better for healing.
ViennaAges 18–70 - NCT06075420Recruiting
Shorter blood thinner use after GENOSS stent in heart disease
This trial tests whether a shorter course of dual antiplatelet therapy (two blood thinners) is safe and effective for people who have received a GENOSS stent for coronary artery disease. It aims to reduce the risk of bleeding while still preventing heart attacks.
Wŏnju, Gangwon StateAges 19 years+ - NCT06011486RecruitingPhase 1
Expanded immune cells for CMV after stem cell transplant
This trial tests a treatment using specially grown immune cells (virus-specific lymphocytes) to fight a stubborn CMV infection that hasn't gotten better with usual medicines. It is for people who have had a stem cell transplant and need help controlling CMV.
São Paulo, São PauloAges 18–75
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,375 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.